483
Cambrex Charles City, Inc.Cambrex Charles City, Inc. – FDA 483, May 2, 2022
Record Details
Cambrex Charles City, Inc. in Charles City, IA, an API manufacturer, was cited for significant deficiencies in laboratory controls and investigation procedures. The inspection revealed issues with scientifically unsound sampling and testing for microbiological contamination and diethylene glycol, as well as untimely and incomplete investigations into manufacturing deviations. These findings indicate a lack of robust quality control and investigation practices.
View Company Profile
ID · 2fd557fc-21d0-48ec-a6ca-112f238f4867
Other documents for Cambrex Charles City, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.